Company news
Dss, Inc. (AMEX:DSS) news
Every Dss, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations
September 8, 2026
DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering
September 4, 2026
DSS, Inc. Withdraws Registration Statement
June 9, 2026
DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing
May 8, 2026
DSS, Inc. Letter to Shareholders
April 15, 2026
DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering
February 5, 2026
DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
February 4, 2026
DSS, Inc. Announces Launch of Proposed Public Offering
February 3, 2026
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
June 24, 2025
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
May 22, 2025
Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Cor...
April 24, 2025
DSS, Inc. Issues Letter to Shareholders
February 3, 2025
DSS : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)
November 13, 2024
DSS : Non Reliance of Financial Report Form 8 K
October 22, 2024
DSS : Amendment to Annual Report Form 10 K/A
October 22, 2024
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
August 26, 2024
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
January 4, 2024
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
December 22, 2023
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Fo...
November 28, 2023
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of C...
November 8, 2023
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
October 23, 2023